UNICYCIVE THERAPEUTICS INC (UNCY) Institutional Ownership Changes & 13F Activity
UNICYCIVE THERAPEUTICS INC (UNCY). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Integral Health Asset Management, Llc, Susquehanna International Group, Llp, Marshall Wace, Llp, and Morgan Stanley.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Bank Of America Corp | Buy | +29,378 | +19327.6% | 29,530 | $194.31K | Q1 2026 | May 18, 2026 |
| Millennium Management Llc | Buy | +384,505 | +37.9% | 1,399,348 | $9.21M | Q1 2026 | May 15, 2026 |
| Integral Health Asset Management, Llc | Buy | +225,000 | — | 225,000 | $1.48M | Q1 2026 | May 15, 2026 |
| Susquehanna International Group, Llp | Buy | +174,288 | +699.1% | 199,219 | $1.31M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Buy | +154,938 | — | 154,938 | $1.02M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +141,598 | +304.0% | 188,182 | $1.24M | Q1 2026 | May 15, 2026 |
| Cantor Fitzgerald, L. P. | Sell | -125,000 | -62.5% | 75,000 | $493.50K | Q1 2026 | May 15, 2026 |
| Diadema Partners Lp | Buy | +106,083 | — | 106,083 | $698.03K | Q1 2026 | May 15, 2026 |
| Diametric Capital, Lp | Buy | +80,362 | — | 80,362 | $528.78K | Q1 2026 | May 15, 2026 |
| Seven Fleet Capital Management Lp | Buy | +55,700 | — | 55,700 | $366.51K | Q1 2026 | May 15, 2026 |
| Barclays Plc | Buy | +49,920 | +62400.0% | 50,000 | $329.00K | Q1 2026 | May 15, 2026 |
| Omers Administration Corp | Sell | -46,300 | -59.2% | 31,900 | $209.90K | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +32,454 | +18.9% | 203,744 | $1.34M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +27,093 | — | 27,093 | $178.27K | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Sell | -21,460 | -8.3% | 236,841 | $1.56M | Q1 2026 | May 15, 2026 |
| State Street Corp | Buy | +14,800 | +22.7% | 80,027 | $526.58K | Q1 2026 | May 15, 2026 |
| Xtx Topco Ltd | Sell | -12,801 | -36.2% | 22,604 | $148.73K | Q1 2026 | May 15, 2026 |
| Prelude Capital Management, Llc | Buy | +12,231 | — | 12,231 | $80.48K | Q1 2026 | May 15, 2026 |
| Quadrature Capital Ltd | Sell | -11,197 | -28.6% | 27,917 | $183.69K | Q1 2026 | May 15, 2026 |
| Acuta Capital Partners, Llc | Sell | -2,026 | -3.4% | 57,959 | $381.37K | Q1 2026 | May 15, 2026 |
| Royal Bank Of Canada | Buy | +377 | — | 377 | $2.00K | Q1 2026 | May 15, 2026 |
| Dauntless Investment Group, Llc | Buy | +57,672 | +64.5% | 147,087 | $967.83K | Q1 2026 | May 14, 2026 |
| Hrt Financial Lp | Buy | +41,492 | — | 41,492 | $273.00K | Q1 2026 | May 14, 2026 |
| Virtu Financial Llc | Buy | +26,274 | — | 26,274 | $173.00K | Q1 2026 | May 14, 2026 |
| Renaissance Technologies LLC | Buy | +24,400 | — | 24,400 | $160.55K | Q1 2026 | May 14, 2026 |
| Simplex Trading, Llc | Buy | +5,820 | — | 5,820 | $38.30K | Q1 2026 | May 14, 2026 |
| Rockefeller Capital Management L.P. | Buy | +1,100 | +220.0% | 1,600 | $10.53K | Q1 2026 | May 14, 2026 |
| Blackrock, Inc. | Sell | -452 | -1.2% | 35,903 | $236.24K | Q1 2026 | May 13, 2026 |
| Jane Street Group, Llc | Buy | +72,243 | — | 72,243 | $475.36K | Q1 2026 | May 12, 2026 |
| Persistent Asset Partners Ltd | Buy | +26,827 | — | 26,827 | $176.52K | Q1 2026 | May 12, 2026 |
Frequently asked questions about UNCY activity
Which institutional owners are buying UNCY?
Institutional owners buying UNCY include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in UNCY activity?
"Buy" means an investor increased their reported position in UNCY compared to the prior reporting period. This reflects growing exposure to UNICYCIVE THERAPEUTICS INC (UNCY) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in UNCY increasing?
Institutional interest in UNCY can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related UNCY Institutional Insights
- UNCY Overview
- UNCY 13F Institutional Holders
- UNCY Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- UNCY Insider Trading & SEC Form 4 Activity
- UNCY Articles
- Top Institutional Investor Stock Rankings